| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | EVP And CCO
3 companies
Yang Michael J. is a Director at Pacira BioSciences, Inc. with holdings across 3 companies. Recent SEC Form 4 filings include 1 buy and 10 sells.
Estimated insider holdings value: $950K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 14, 2024 | PCRX Pacira Biosciences, Inc. | Director | Buy | 2,000 | $12.90 | $25,800.00 | +38.2% | +34.7% | +100.4% | |
| Jan 6, 2021 | ACAD Acadia Pharmaceuticals Inc | EVP And CCO | Sale+OE | 1,120 | $53.34 | $59,740.80 | -12.2% | - | - | |
| Oct 16, 2020 | ACAD Acadia Pharmaceuticals Inc | EVP And CCO | Sale+OE | 1,247 | $42.56 | $53,072.32 | -16.2% | - | - | |
| Jul 7, 2020 | ACAD Acadia Pharmaceuticals Inc | EVP And CCO | Sale+OE | 27,250 | $56.25 | $1,532,786.37 | -55.9% | - | - | |
| Apr 30, 2020 | ACAD Acadia Pharmaceuticals Inc | EVP And CCO | Sale+OE | 1,501 | $49.21 | $73,864.21 | -22.4% | - | - | |
| Dec 12, 2019 | ACAD Acadia Pharmaceuticals Inc | EVP And CCO | Sale+OE | 105,479 | $44.46 | $4,689,262.89 | -91.3% | - | - | |
| Dec 9, 2019 | ACAD Acadia Pharmaceuticals Inc | EVP And CCO | Sale+OE | 14,521 | $50.46 | $732,792.26 | -68.3% | - | - | |
| Oct 15, 2019 | ACAD Acadia Pharmaceuticals Inc | EVP And CCO | Sale+OE | 877 | $39.65 | $34,773.05 | -35.1% | - | - |